Clinical trial NCT02417454: Study on the Effects of a Probiotic on Autonomic and Psychological Stress
Official title: A Double Blind Placebo Controlled Study on the Effects of a Probiotic on Autonomic and Psychological Stress Responses in Volunteers
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Stress, Psychological
Keywords: probiotic
stress
emotion psychophysiology
brain-body-gut interactions
Lead sponsor: McMaster University
Sponsor class: OTHER
Collaborators: name: Lallemand Health Solutions
First posted: 2015-04-15
Enrollment: 128
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to investigate the effects of a probiotic blend on qualitative (subjective interviews and self-reporting) and quantitative (changes in brain activity, heart rate, cortisol, and reactivity) measures of stress in healthy undergraduate students.

Detailed description: There is a burgeoning literature involving nonhuman animal and human studies linking the microbiota environment in the gut to brain-behaviour relations. For example, animal studies demonstrate that germ-free rodents show heightened HPA-axis responses to stress compared to gnotobiotic animals. There are also a number of nonhuman and human studies that show positive effects of reducing stress after being treated with different probiotics. For example, in one recent double blind study in humans using standardized questionnaires indicated a greater reduction of stress and anxiety symptoms after one month of supplementation with a probiotic formulation compared to placebo. The groups were also differentiated by urinary cortisol levels after treatment. Other studies have found positive effects of probiotic treatment and stress reduction using other probiotics. Accordingly, there is accumulating empirical evidence from animal and human studies of the positive effects of probiotic treatment on stress reduction.

In this study, the investigators will investigate the stress reduction effects of the Lallemand Health Solutions (LHS) Probio'Stick® on healthy undergraduate students. The study will be conducted at the McMaster LIVELab, which is capable of collecting both physiological and behavioural measures from groups of up to 100 participants at a time.

Registration into this clinical trial will require students be screened via McMaster's SONA system (mcmaster.sona-systems.com). After the screening, participants that are eligible to participate will be given the option to register for an information meeting at which point one may opt to enrol in the study or not.

Once in the study, participants will undergo an initial screening in the LIVELab where they will be exposed to auditory, visual, and performance based stressors to measure a baseline. After such point, they will be randomized to receive Probio'Stick® or placebo for a 6-week, once daily, probiotic treatment at home. Following the 6 week intervention, participants will return to the lab for a second testing using the same procedures to establish a change from baseline.

Eligibility criteria: Inclusion Criteria:

* Answering "Yes" to questions 3, 8 and 9 of the Cohen's Perceived Stress Scale.
* Willingness to complete questionnaires, records, and diaries associated with the study and to complete all site visits.
* Willingness to discontinue consumption of fermented foods or probiotics (e.g. yogurts, with live, active cultures, or supplements).
* Ability to provide informed consent.

Exclusion Criteria:

* Must not be currently taking another probiotic regiment or another investigational product within 3 months of the screening visit.
* Must not currently be taking medications for depression or anxiety, including benzodiazepines, SSRIs, or antipsychotics or receiving counselling for depression or anxiety.
* Must not be immune-compromised or immuno-suppressed (e.g. AIDS, lymphoma, participants undergoing long-term corticosteroid treatment, chemotherapy and allograft participants).
* Must not have experienced bloody diarrhea in the past month prior to beginning the study.
* Must not have undergone any surgery within the three months prior to beginning the study, particularly surgeries involving the colon.
* Must not have any soy or milk allergy.
* Must not be pregnant or breast-feeding or planning on becoming pregnant.
* Must not have used of any antibiotic drug (e.g., neomycin, rifaximin) within 1 month of screening.

Primary outcomes:
measure: Changes in right frontal electroencephalography (EEG)/brain activity
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
measure: Changes in salivary cortisol concentrations
timeFrame: Pre and Post Visit 1 and Visit 2 (6 weeks apart)
measure: Change in the magnitude of startle response
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
measure: Changes in sympathetic nervous system activation
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
Secondary outcomes:
measure: Changes in Anxiety Scores as determined by the Beck Anxiety Inventory (BAI)
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
measure: Changes in Stress Scores as determined by Cohen's Perceived Stress Scale (PSS)
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
measure: Changes in General Affect Scores as determined by the Positive and Negative Affect Scale (PANAS)
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
measure: Changes in Stress Scores as reported on a 1-10 Likert Scale
timeFrame: Visit 1 and Visit 2 (6 weeks apart)
Other outcomes:
Locations:
city: Hamilton
country: Canada
facility: McMaster LIVELab
state: Ontario
Study officials:
affiliation: McMaster University
name: Laurel Trainor, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
citation: Lutgendorff F, Akkermans LM, Soderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med. 2008 Jun;8(4):282-98. doi: 10.2174/156652408784533779.
citation: Ait-Belgnaoui A, Colom A, Braniste V, Ramalho L, Marrot A, Cartier C, Houdeau E, Theodorou V, Tompkins T. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil. 2014 Apr;26(4):510-20. doi: 10.1111/nmo.12295. Epub 2013 Dec 30.
citation: Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012 Nov;37(11):1885-95. doi: 10.1016/j.psyneuen.2012.03.024. Epub 2012 Apr 26.
citation: Palomar MM, Maldonado Galdeano C, Perdigon G. Influence of a probiotic lactobacillus strain on the intestinal ecosystem in a stress model mouse. Brain Behav Immun. 2014 Jan;35:77-85. doi: 10.1016/j.bbi.2013.08.015. Epub 2013 Sep 7.
citation: Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, Zilmer M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr. 2003 Aug;90(2):449-56. doi: 10.1079/bjn2003896.
citation: Messaoudi M, Violle N, Bisson JF, Desor D, Javelot H, Rougeot C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes. 2011 Jul-Aug;2(4):256-61. doi: 10.4161/gmic.2.4.16108. Epub 2011 Jul 1. No abstract available.
citation: Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
citation: Lang PJ, Bradley MM, Cuthbert BN. International affective picture system (IAPS): Affective ratings of pictures and instruction manual.. Technical Report A-8. University of Florida, Gainesville, FL.; 1995.
citation: Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Past. 1994;92:45-67.
citation: Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fonden R, Saxelin M, Collins K, Mogensen G, Birkeland SE, Mattila-Sandholm T. Demonstration of safety of probiotics -- a review. Int J Food Microbiol. 1998 Oct 20;44(1-2):93-106. doi: 10.1016/s0168-1605(98)00128-7.
citation: European Food Safety Authority (EFSA). Technical guidance - Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J. 2008 Jul 14;6(7):732. doi: 10.2903/j.efsa.2008.732. eCollection 2008 Jul. No abstract available.
citation: Garneau P, Labrecque O, Maynard C, Messier S, Masson L, Archambault M, Harel J. Use of a bacterial antimicrobial resistance gene microarray for the identification of resistant Staphylococcus aureus. Zoonoses Public Health. 2010 Nov;57 Suppl 1:94-9. doi: 10.1111/j.1863-2378.2010.01358.x.